{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:02Z","timestamp":1761513182677,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.3816\/cbc.2006.n.003","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:07:37Z","timestamp":1221080857000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Phase II Trial of Weekly Docetaxel\/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer"],"prefix":"10.3816","volume":"6","author":[{"given":"Joyce A.","family":"O'Shaughnessy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pluenneke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Des","family":"Ilegbodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2006.n.003_bib1","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1995.13.11.2731","article-title":"Advanced breast cancer: a phase II trial with gemcitabine","volume":"13","author":"Carmichael","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib2","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.1999.17.8.2341","article-title":"Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer","volume":"17","author":"Chan","year":"1999","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.3816\/CBC.2006.n.003_bib3","first-page":"S9","article-title":"Randomized trial comparing docetaxel and paclitaxel in patients with metastatic breast cancer","volume":"82","author":"Jones","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2006.n.003_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.1999.17.5.1413","article-title":"Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracyclinecontaining chemotherapy","volume":"17","author":"Nabholtz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0959-8049(99)00122-7","article-title":"Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group","volume":"35","author":"Sj\u00f6str\u00f6m","year":"1999","journal-title":"Eur J Cancer"},{"issue":"suppl 13","key":"10.3816\/CBC.2006.n.003_bib6","first-page":"S13-11","article-title":"Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy","volume":"24","author":"Valero","year":"1997","journal-title":"Semin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib7","first-page":"5","article-title":"Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): first report of overall survival","volume":"23","author":"Albain","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib8","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.1998.16.6.2164","article-title":"Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer","volume":"16","author":"Hainsworth","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib9","first-page":"125","article-title":"Dose-dense weekly docetaxel (Taxotere\u00ae) in metastatic breast cancer","volume":"57","author":"Loeffler","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2006.n.003_bib10","first-page":"262","article-title":"Weekly docetaxel treatment in metastatic breast cancer: a phase I\/II study","volume":"50","author":"Scholz","year":"1998","journal-title":"Breast Cancer Res Treat"},{"issue":"suppl 14","key":"10.3816\/CBC.2006.n.003_bib11","first-page":"S14","article-title":"Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results","volume":"24","author":"Georgoulias","year":"1997","journal-title":"Semin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib12","first-page":"106a","article-title":"Second-line chemotherapy with weekly gemcitabine (GEM) and monthly docetaxel (DOC) in patients (pts) with metastatic breast cancer (MBC): a phase II study","volume":"19","author":"Laufman","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000048244","article-title":"Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study","volume":"62","author":"Brugnatelli","year":"2002","journal-title":"Oncology"},{"key":"10.3816\/CBC.2006.n.003_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1023\/A:1008377819875","article-title":"Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma","volume":"10","author":"Dunsford","year":"1999","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/cncr.10843","article-title":"A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung cancer","volume":"95","author":"Popa","year":"2002","journal-title":"Cancer"},{"key":"10.3816\/CBC.2006.n.003_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-5002(00)00243-9","article-title":"Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer","volume":"33","author":"Rebattu","year":"2001","journal-title":"Lung Cancer"},{"key":"10.3816\/CBC.2006.n.003_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000048240","article-title":"Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial","volume":"62","author":"Blackstein","year":"2002","journal-title":"Oncology"},{"key":"10.3816\/CBC.2006.n.003_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdf027","article-title":"Phase II study of weekly docetaxel in patients with metastatic breast cancer","volume":"13","author":"Aihara","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.2000.18.6.1212","article-title":"Docetaxel administered on a weekly basis for metastatic breast cancer","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib20","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1200\/JCO.2001.19.15.3500","article-title":"Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial","volume":"19","author":"Hainsworth","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib21","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1023\/A:1012557528952","article-title":"Weekly docetaxel (Taxotere \u00ae) in patients with metastatic breast cancer","volume":"12","author":"Stemmler","year":"2001","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib22","first-page":"1051","article-title":"Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor","volume":"8","author":"Kornek","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2006.n.003_bib23","first-page":"45b","article-title":"Weekly docetaxel (doc) + gemcitabine (gem) as first line therapy for advanced breast cancer (ABC): a multicenter phase II study","volume":"21","author":"Palmeri","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib24","first-page":"35b","article-title":"Gemcitabine and docetaxel given every 2 weeks as first-line therapy for metastatic breast cancer (MBC): results of a GEICAM phase II study","volume":"21","author":"Pelegri","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07357900009012188","article-title":"Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group phase II study","volume":"18","author":"Fountzilas","year":"2000","journal-title":"Cancer Invest"},{"key":"10.3816\/CBC.2006.n.003_bib26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1023\/A:1012247311419","article-title":"Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial","volume":"12","author":"Laufman","year":"2001","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2006.n.003_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1008315723253","article-title":"Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial","volume":"10","author":"Mavroudis","year":"1999","journal-title":"Ann Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911704700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911704700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:08:46Z","timestamp":1761512926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911704700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1526820911704700"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2006.n.003","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase II Trial of Weekly Docetaxel\/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2006.n.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}